Hengkang Medical Group Co., Ltd.
Symbol: 002219.SZ
SHZ
2.47
CNYMarktpreis heute
249.1204
P/E-Verhältnis
78.8881
PEG-Verhältnis
8.42B
MRK Kapital
- 0.00%
DIV Rendite
Hengkang Medical Group Co., Ltd. (002219-SZ) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 2320.73 | 580.2 | 558.9 | 2033.2 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | -129.17 | 0 | 0 | -66.5 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 4854.98 | 1121.5 | 1056.1 | 784.2 | ||||||||||||||||||||
balance-sheet.row.inventory | 838.46 | 218.5 | 164.4 | 185.3 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 84.61 | 35.7 | 17.9 | 21.2 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 8098.77 | 1956 | 1797.3 | 3023.8 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 10328.04 | 2638.3 | 2470 | 2308.8 | ||||||||||||||||||||
balance-sheet.row.goodwill | 3731.36 | 949 | 884.1 | 884.1 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 1169.52 | 304.4 | 265.6 | 274 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 4900.88 | 1253.4 | 1149.7 | 1158.1 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 155.91 | 6.9 | 5.9 | 72.6 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 643.59 | 160.4 | 141.2 | 126.2 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 205.88 | 65.2 | 78 | 0.7 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 16234.3 | 4124.2 | 3844.8 | 3666.4 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 24333.07 | 6080.2 | 5642.1 | 6690.2 | ||||||||||||||||||||
balance-sheet.row.account-payables | 5233.56 | 1299.6 | 1161.3 | 1000.4 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 3965.62 | 1168.7 | 1127.7 | 2103.6 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 119.33 | 13.8 | 60.1 | 53.2 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 3055.43 | 722.2 | 456.2 | 335.3 | ||||||||||||||||||||
Deferred Revenue Non Current | 9.33 | 2.9 | 2.1 | 2.1 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 158.59 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 573.29 | 373.9 | 968.4 | 59.5 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 3609.48 | 919.5 | 552.7 | 545.8 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 341.92 | 165.9 | 45.7 | 55.3 | ||||||||||||||||||||
balance-sheet.row.total-liab | 15514.97 | 3842.8 | 3876.7 | 5104.2 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 13585.04 | 3410.8 | 3264.2 | 1865.2 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | -12196.33 | -3062 | -3093.4 | -3249 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 4004.15 | 129.2 | 129.5 | 129.5 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3262.4 | 1717.7 | 1422.9 | 2807.4 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 8655.26 | 2195.7 | 1723.1 | 1553.1 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 24333.07 | 6080.2 | 5642.1 | 6690.2 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 159.97 | 38.8 | 42.2 | 33 | ||||||||||||||||||||
balance-sheet.row.total-equity | 8815.23 | 2234.5 | 1765.4 | 1586.1 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 24333.07 | - | - | - | ||||||||||||||||||||
Total Investments | 26.73 | 6.9 | 5.9 | 6.1 | ||||||||||||||||||||
balance-sheet.row.total-debt | 7186.99 | 2056.9 | 1583.9 | 2438.9 | ||||||||||||||||||||
balance-sheet.row.net-debt | 4866.36 | 1476.7 | 1024.9 | 405.8 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 33.61 | 30.8 | 164.3 | -367.3 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 39.95 | 238.7 | 166.5 | 163.3 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 35.49 | -34.1 | -19.4 | -23.1 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 78.12 | -650.2 | 19.4 | 23.1 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | -11.62 | -172.9 | -205.7 | -28.8 | ||||||||||||||||||||
cash-flows.row.account-receivables | 16.16 | -195.6 | -160.1 | -70.2 | ||||||||||||||||||||
cash-flows.row.inventory | -27.78 | -52.3 | 20.8 | -7.3 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | 74.9 | -47 | 71.8 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -19.4 | -23.1 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 205.93 | 879 | 143 | 510.1 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 264.29 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -211.07 | -195.2 | -221.6 | -198.7 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | -67.23 | -139.2 | 49 | -1 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | -128.1 | -128.1 | -122.6 | -1 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1.1 | 0.1 | 0.5 | 1 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | 126.48 | 127 | 102.3 | 0.6 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -279.02 | -335.4 | -192.3 | -199.1 | ||||||||||||||||||||
cash-flows.row.debt-repayment | -177.44 | -626.4 | -1063.2 | -284.7 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -19.51 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.dividends-paid | -102.41 | -104 | -275.8 | -54.2 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | -59.7 | -563.6 | -190 | 2108.4 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -275.2 | 62.8 | -1529 | 1769.5 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | -284.06 | 20.9 | -1453.2 | 1847.7 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 2252.92 | 580.2 | 537.9 | 1991.1 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2536.98 | 559.4 | 1991.1 | 143.4 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 264.29 | 291.2 | 268 | 277.3 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | -211.07 | -195.2 | -221.6 | -198.7 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | 53.23 | 96.1 | 46.5 | 78.6 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 3667.58 | 3568.4 | 3152.7 | 3016.1 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 2599.38 | 2579.8 | 2160.1 | 2208.4 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 1068.2 | 988.6 | 992.6 | 807.7 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 30.87 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 235.47 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 202.79 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | -12.31 | -0.4 | 318.1 | 322.5 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 875.08 | 861.8 | 691.4 | 721.4 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 3474.47 | 3441.6 | 2851.5 | 2929.8 | ||||||||||||||||||||
income-statement-row.row.interest-income | 10.95 | 11.4 | 11.8 | 0.9 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 127.56 | 120.6 | 142.6 | 230 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 202.79 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -42.81 | -116.5 | -170.6 | -516.3 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -12.31 | -0.4 | 318.1 | 322.5 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -42.81 | -116.5 | -170.6 | -516.3 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 127.56 | 120.6 | 142.6 | 230 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 200.83 | 238.7 | 166.5 | 163.3 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 258.8 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 57.97 | 126.8 | 358 | 153.9 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 15.16 | 10.3 | 187.5 | -362.4 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | -26.88 | -28.7 | 23.2 | 4.9 | ||||||||||||||||||||
income-statement-row.row.net-income | 33.61 | 30.8 | 156.1 | -367.3 |
Häufig gestellte Frage
Wie hoch ist die Hengkang Medical Group Co., Ltd. (002219.SZ) Gesamtvermögen?
Hengkang Medical Group Co., Ltd. (002219.SZ) Gesamtvermögen ist 6080204990.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 1938687759.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.291.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 0.016.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.009.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.016.
Was ist der Hengkang Medical Group Co., Ltd. (002219.SZ) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 30776551.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 2056894679.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 861844189.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 493711477.000.